Caroline Barelle

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom.

Panmure Gordon (UK) Ltd. (PGL) is the stockbroking subsidiary of Panmure Gordon & Co. Ltd. in Great Britain. Headquartered in London, the firm was founded in 2003 and provides corporate finance advice, distributes and trades securities and produces investment research to UK small and mid-cap corporates and investment companies. PGL has access to capital markets via a range of equity and equity-linked products such as IPOs, accelerated book buildings, placings, rights issues, and bought deals. The firm's institutional equities department provides UK-focused research, sales and trading services to institutional investors in the UK, US and Europe.

F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria.

Part of Bioven Holdings Sdn. The company is based in Aberdeen, UK. The British company manufactures and develops pharmaceutical products. Bhd., In3Bio Research Ltd. is a pharmaceutical company founded in 2009.

AgrEvo GmbH manufacturers fertilizer products. It offers crop protection and production products including seeds, pest control products and other bio- technology products. The company is headquartered in Berlin, Germany.

Haptogen Ltd. manufactures biopharmaceuticals products. The company was founded by Jim Reid in 2002 and is headquartered in Aberdeen, UK.

NovaBiotics Ltd. operates as a clinical-stage biotechnology firm. It designs and develops antifungal and antibacterial therapeutics for medically unmet fungal, bacterial, and polymicrobial conditions. It offers clinical and preclinical product candidates to treat clinically challenging infections that include NP213 (Novexatin) phase IIb-ready potent topical treatment for fungal nail infections (onychomycosis); NM001 (Lynovex), a dual antibacterial-mucolytic orphan drug candidate in phase IIa clinical evaluation for cystic fibrosis; NP339 (Novamycin), an antifungal peptide agent against Candida spp and other clinically relevant yeasts/moulds; and NP432 (Novarifyn), a peptide antibacterial candidate for multi-drug resistant gram-negative and gram-positive infections. The company was founded by Deborah A. O?Neil in August 2004 and is headquartered in Aberdeen, the United Kingdom.

Cytosystems Ltd. develops advanced diagnostic techniques for cancer. Its products include BladderLight, a urine-based screening and diagnostic solution for the detection of cancer of the bladder and the prostate. The company was founded by David Galloway in 2006 and is headquartered in Aberdeen, the United Kingdom.

Zilico Ltd. develops medical device to detect cervical cancer and pre-cancerous cells in the cervix. It focuses on developing a research-based instrument into a device (system) appropriate for commercial manufacture and routine use by medical practitioners. The firm consists of a handheld device and a base unit together with a single-use disposable sleeve for each test. The company was founded by John Tidy and Brian Brown on February 28, 2006 and is headquartered in Manchester, the United Kingdom.

Grampian Biopartners Ltd. specializes in seed funding early stage life-science companies. It also offers consultancy services, such as technical and commercial due diligence. The firm focuses on covers immuno-diagnostics and devices, immuno-technology, biologic drug discovery. The company was founded by Andrew Justin Radcliffe Porter, Gillian Broadbent and Keith Charlton in March 2008 and is headquartered in Aberdeen, the United Kingdom.

Business Growth Fund Ltd (BGF) is private equity firm founded in 2011 by Stephen Welton. The firm is headquartered in the United Kingdom.

Renephra Ltd. develops medical devices. Its is developing ground-breaking new approaches to dialysis treatment in end-stage renal disease by accessing the interstitial fluid in the skin. This new approach enables water and toxin removal in a non-invasive manner. The company was founded by Paul Brenchley and Sandip Mitra in 2009 and is headquartered in Manchester, the United Kingdom.

Ibisvision Ltd. develops software program for early detection of glaucoma. It offers ringof sight test which be hosted remotely and deployed via the in cloud technology enabling clients to access the application. The company was founded by Blair Donaldson and is headquartered in Glasgow, the United Kingdom.

Glyconics Ltd. develops medical devices for COPD and provides diagnostic testing services. The company was founded on October 22, 2013 and is headquartered in Norwich, the United Kingdom.

Deepbridge Capital LLP (Deepbridge) is an investment management firm founded in 2010. The firm is headquartered in Chester, UK.

Acorn Partners Ltd. develops and produces digital products and solutions within the health care sector. The company was founded by Savvas Ioannou Neophytou on May 19, 2016 and is headquartered in Liverpool, the United Kingdom.

Transcriptogen Ltd. operates as a drug discovery company to exploit the use of small molecules to inhibit the interaction of transcription factors (TFs) with their cognate DNA-recognition site, thus down-regulating or inhibiting the transcription of disease-related genes. The firm develops and discovers anti-cancer drugs. The company was founded by Khondaker Miraz Rahman, Paul Jackson, and Sheraz Gul and is headquartered in Bath, the United Kingdom.

Care Cube Solutions Ltd. operates as networked digital workflow system designed by cardiologists for users to simplify and centralize the tracking of patient flow in cardiology departments. Its solutions interacts with existing hospital systems such as the PAS (Patient Administration System) and EPR (Electronic Patient Records). The company was incorporated on June 24, 2015 and is headquartered in Solihull, the United Kingdom.

Stent Tek Ltd. develops novel catheter based system. It provides patients to receive hemodialysis for kidney failure. The firm dialysis machine hooked up to a specific vein, known as the vascular access to filter their blood. The company was founded in 2014 by Sorin Popa and Robert J. Dickinson and is headquartered in South Kensington, the United Kingdom.

Peptigeldesign Ltd. develops peptide based hydrogels for biomedical and biotechnological applications, stem-cell culture and tissue engineering. It offers cardiovascular and synthetic extra cellular matrix products. The company was founded by Guillaume Saint-Pierre, Aline F Miller and Alberto Saiani and is headquartered in Alderley Edge, the United Kingdom.

Metix Ltd. operates as a medical technology company which develops robust handheld digital signs monitor and patient monitoring solutions. It offers a range of multi-parameter patient monitoring solutions which are capable of operating in all pre-hospital care environments from the Arctic to the Jungle. The company was founded by Julio Enrique Guerrero Ontiveros and Pablo Perez Villanueva in 2013 and is headquartered in Glasgow, the United Kingdom.

Real Space Ltd. engages in the manufacture of optical precision instruments. The company was founded on April 24, 2016 and is headquartered in Liverpool, the United Kingdom.

Torafugu Tech Ltd. develops AI-based software for the insurance sector. The company is based in Chester, UK. The British company was founded in 2016 by Savvas Ioannou Neophytou.

Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom.

Tookie Ltd. develops a portfolio of products which seek to assist patients with medical problems surrounding the securing of central venous catheters. The firm's products include patient, focusing upon security of Central Venous Catheters (CVC) and also incorporating lines for other patient groups – addressing unmet clinical and patient needs. The company was founded in 2015 and is headquartered in Liverpool, the United Kingdom.

Allergy Free Restaurants Ltd. engages in the provision of serving allergy free food menus. The company was founded by Sunil Mistry on April 28, 2017 and is headquartered in Liverpool, the United Kingdom.

Macomics Ltd. engages in research and experimental development on biotechnology. The company was founded by Jeffrey William Pollard and Luca Cassetta on November 6, 2018 and is headquartered in Edinburgh, the United Kingdom.

Spirea Ltd. operates as a healthcare technology company. It develops smart polymer platform for the controlled delivery of drug combinations to maximise the clinical impact of medicines. The company was founded by Myriam Ouberai and is headquartered in arrogate, the United Kingdom.

Busy Kids Ltd. engages in the development of medical software. The company was founded on April 28, 2017 and is headquartered in Liverpool, the United Kingdom.

NanoSyrinx Ltd is a discovery stage biotechnology company that is based in the UK. The British company is focused on developing protein nanosyringes as a new way to deliver protein and peptide biologic drugs intracellularly. The company uses synthetic biology approaches to achieve this goal. The company was founded by Joseph Healey, Alexia Hapeshi, and Nicholas Waterfield, with Joseph Healey serving as the CEO since incorporation.

School Wellbeing Accelerator Ltd. provides resources to improve staff wellbeing in schools. The company is based in Liverpool, UK. The British company's offerings include a free learning center and comprehensive tools for use in schools. The company was founded in 2018 by Mark David Solomons, who has been the CEO since 2018.

Manchester Biogel Ltd design and manufacture synthetic self-assembling peptide hydrogels. It offers PeptiGel, Peptlinks and Bespoke services. The company was founded by Aline Miller and Alberto Saiani on April 10, 2016 and is headquartered in Alderley Edge, the United Kingdom.